Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulating the Radiation Response.

Coleman1

  • 1Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts, 02115, USA.

The Oncologist
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine (FCH) as a PET Tumor Imaging Agent.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2001
Same author

27. PET Image Interpretation. Attenuation-Corrected (ATN) Vs Non-Attenuation Corrected (NATN) Images.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2001
Same author

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey.

The Journal of antimicrobial chemotherapy·2000
Same author

Gap-anisotropic model for the narrow-Gap kondo insulators

Physical review letters·2000
Same author

Observation of CP violation in K(L)-->pi(+)pi(-)e(+)e(-) decays

Physical review letters·2000
Same author

Search for the weak decay of a lightly bound H0 dibaryon

Physical review letters·2000
Same journal

Durable Response to Sotorasib in KRAS G12C-Mutant Intrahepatic Cholangiocarcinoma: A Case Report.

The oncologist·2026
Same journal

The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.

The oncologist·2026
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
See all related articles

This review explores strategies to enhance tumor response and protect normal tissues from ionizing radiation. Advances in tumor biology are improving radiation sensitization and protection methods.

Area of Science:

  • Oncology
  • Radiation Biology
  • Molecular Biology

Background:

  • Ionizing radiation is a cornerstone of cancer treatment, but its efficacy is limited by tumor resistance and damage to surrounding normal tissues.
  • Understanding tumor, cellular, and molecular biology is crucial for improving radiation therapy outcomes.
  • Hypoxic cell sensitizers have shown clinical utility, but further advancements are needed.

Purpose of the Study:

  • To review current and future strategies for modulating tumor and normal tissue responses to ionizing radiation.
  • To explore how emerging biological knowledge can enhance radiation sensitization and protection.
  • To discuss the clinical implications of novel approaches in radiation oncology.

Main Methods:

  • Literature review of current research and clinical trials in radiation oncology.

Related Experiment Videos

  • Analysis of emerging data in tumor, cellular, and molecular biology.
  • Synthesis of information on hypoxic cell sensitizers and novel radiation modulators.

    • Main Results:

    • Emerging biological insights are improving the understanding of clinical outcomes with radiation therapy.
    • Novel approaches are being developed to sensitize tumors to radiation and protect normal tissues.
    • Hypoxic cell sensitizers represent one class of agents being refined for clinical use.

    Conclusions:

    • Modulating the response to ionizing radiation holds significant promise for improving cancer treatment.
    • Continued integration of biological knowledge is key to developing more effective and safer radiation therapies.
    • Future strategies will likely involve a combination of targeted biological agents and advanced radiation techniques.